Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Merck
Boehringer Ingelheim
Express Scripts
Harvard Business School

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Hikma Pharms Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HIKMA PHARMS, and what generic and branded alternatives to HIKMA PHARMS drugs are available?

HIKMA PHARMS has fifty-three approved drugs.

There are two tentative approvals on HIKMA PHARMS drugs.

Summary for Hikma Pharms
US Patents:0
Tradenames:45
Ingredients:45
NDAs:53

Drugs and US Patents for Hikma Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms ACYCLOVIR SODIUM acyclovir sodium INJECTABLE;INJECTION 205771-001 Feb 29, 2016 DISCN No No   Start Trial   Start Trial
Hikma Pharms AMLODIPINE BESYLATE amlodipine besylate TABLET;ORAL 077771-002 Apr 12, 2011 AB RX No No   Start Trial   Start Trial
Hikma Pharms CEPHALEXIN cephalexin FOR SUSPENSION;ORAL 065444-002 Aug 28, 2009 DISCN No No   Start Trial   Start Trial
Hikma Pharms PARICALCITOL paricalcitol SOLUTION;INTRAVENOUS 205917-001 Nov 18, 2014 AP RX No No   Start Trial   Start Trial
Hikma Pharms BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine CAPSULE;ORAL 040261-001 Oct 28, 1998 DISCN No No   Start Trial   Start Trial
Hikma Pharms FOLIC ACID folic acid TABLET;ORAL 080600-001 Approved Prior to Jan 1, 1982 AA RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
McKinsey
Johnson and Johnson
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.